TITLE

Caution with a useful Agent

AUTHOR(S)
Trethowan, W. H.
PUB. DATE
June 1974
SOURCE
British Medical Journal;6/8/1974, Vol. 2 Issue 5918, p566
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
64110720

 

Related Articles

  • Additives - Wetting agents & surfactants. Veeramani // Paintindia;Apr2015, Vol. 65 Issue 4, p104 

    This article provides information on wetting agents and surfactants. It discusses the functions of wetting agents and surfactants, the use of phosphate esters, the contribution of surfactants to wetting and dispersion, cautions in using surfactants and the advantages of using surfactants in a...

  • Caution urged in use of thrombolytic therapy to minimize stroke-related neurologic deficits. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;09/25/97, Vol. 10 Issue 9, p26 

    Discusses the need for caution in the use of thrombolytic therapy in coronary heart disease. Therapeutic uses of thrombolytic agents stroke-related neurological diseases; Termination of clinical trials due to risk of cerebral hemorrhage.

  • Anti-VEGF therapy effective in ROP but requires caution.  // Ocular Surgery News;4/25/2012, Vol. 30 Issue 8, p18 

    The article reports on the recommendation of Paul Chan for caution and diligent follow-up in the use of anti-vascular endothelial growth factor (VEGF) agents despite their proven effectiveness and superiority over laser in the treatment of retinopathy of prematurity.

  • A new diabetes drug to replace a toxic one? Cerrato, Paul L. // RN;Aug99, Vol. 62 Issue 8, p87 

    Reports on the United States Food and Drug Administration's (FDA) approval of rosiglitazone (Avandia) as a replacement for the toxic antidiabetic agent troglitazone (Rezulin). Background information about the drugs; FDA caution prior to rosiglitazone use.

  • THE ARTHRITIS TODAY GUIDE TO: biologics. Matteson, Eric L. // Arthritis Today;Jul/Aug2008, Vol. 22 Issue 4, p56 

    The article presents guidelines for administering biologic agents. It cites several biologics including Adalimumab, Etanercept, Abatacept, Infliximab, Rituximab and Anakinra with corresponding dosage and instructions. It also notes the possible side effects and discusses cautions of using these...

  • MEZIC ET AL. RESPOND. Mezic, Igor; Gruenewald, Paul J.; Gorman, Dennis M.; Mezic, Jadranka // American Journal of Public Health;May2007, Vol. 97 Issue 5, p781 

    A letter to the editor is presented in response to the previously published letter "Agent-Based Modeling: Use With Necessary Caution," by G. T. Jones from the May 2007 issue.

  • Volatile agents for ICU sedation? Bracco, David; Donatelli, Francesco // Intensive Care Medicine;Jun2011, Vol. 37 Issue 6, p895 

    The authors reflect on the adoption of volatile agent sedation in the intensive care unit (ICU). They argue that the implementation of sedation process in the ICU requires an engineering upgrade for technical investments and for gas-scavenging infrastructure. An overview of the use of...

  • Credit Cards. Patel, Amit // Scholastic Choices;Feb/Mar2005, Vol. 20 Issue 5, p31 

    Alerts people to use credit cards but with cautions.

  • Effect of dobutamine on insulin requirement in diabetic ketoacidosis. Wood, S.M.; Milne, J.R.; Evans, S.F.; Rogers, P. // British Medical Journal (Clinical Research Edition);3/21/1981, Vol. 282 Issue 6268, p946 

    Investigates the effect of dobutamine on insulin requirement in diabetic ketoacidosis. Increase of insulin requirement; Relation between the use of dobutamine and insulin resistance; Use of dobutamine as an inotropic agent; Need for caution in the use of dobutamine and other beta-agonists in...

  • Circulatory collapse after oral oxprenolol. Brooks, Nicholas H. // British Medical Journal;10/4/1975, Vol. 4 Issue 5987, p24 

    Presents a case report of circulatory collapse after oral oxprenolol. Use of beta-adrenergic blocking agents in the treatment of hypertension; Analysis of the intrinsic sympathomimetic activity of beta-blockers; Caution for using beta-blocking drugs in the impairment of myocardial performance.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics